<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01073384</url>
  </required_header>
  <id_info>
    <org_study_id>BDP-ENT-01</org_study_id>
    <secondary_id>1R43CA141968-01</secondary_id>
    <nct_id>NCT01073384</nct_id>
  </id_info>
  <brief_title>A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer</brief_title>
  <official_title>A Phase 1/2 Study to Evaluate Escalating Doses of SGX201 [Delayed Release Oral Beclomethasone Dipropionate (BDP)] for Prevention of Signs and Symptoms of Acute Enteritis in Patients With Rectal Cancer Treated With Combined Chemotherapy and Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soligenix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Soligenix</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and preliminary efficacy of four doses of
      SGX201 in subjects with rectal cancer treated with concurrent radiation and chemotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preliminary Efficacy</measure>
    <time_frame>One day prior to and 7 days after radiation therapy</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Enteritis</condition>
  <arm_group>
    <arm_group_label>BDP 3 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg TID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BDP 6 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 mg TID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BDP 9 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 mg TID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BDP 12 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 mg TID</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SGX201 (delayed release beclomethasone 17,21-dipropionate)</intervention_name>
    <description>Delayed release beclomethasone 17,21-dipropionate before the first administration of radiation therapy continuing for 7 days after the end of radiation therapy.</description>
    <arm_group_label>BDP 3 mg</arm_group_label>
    <arm_group_label>BDP 6 mg</arm_group_label>
    <arm_group_label>BDP 9 mg</arm_group_label>
    <arm_group_label>BDP 12 mg</arm_group_label>
    <other_name>beclomethasone 17,21-dipropionate</other_name>
    <other_name>17,-21 BDP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary rectal cancer

          -  Planned course of conventional neoadjuvant radiation therapy before surgery

          -  Scheduled to receive chemotherapy

          -  &gt;/= 18 years of age

          -  Negative pregnancy test

        Exclusion Criteria:

          -  History of acute or chronic regional enteritis or inflammatory bowel disease

          -  Stool incontinence

          -  Uncontrollable diarrhea

          -  Abdominal-perineal resection or other surgery leaving patient without a functioning
             rectum

          -  Patients using colostomy or ileostomy

          -  Liver function tests &gt; 3x upper limit of normal, or bilirubin test result &gt; 1.5 the
             upper limit of normal

          -  Calculated creatinine clearance &lt;60 mL/minute

          -  Planned hyperfractionated or split course radiation

          -  Planned brachytherapy prior to completion of all external beam radiation therapy

          -  Prior pelvic RT

          -  An on-going infection

          -  ECOG score &gt;/= 3

          -  Leukopenia &lt;2,000 WBC/mm3 or Hg &lt;10.5 g/dL

          -  Participation in an investigational drug trial within the previous 30 days

          -  Patients with a medical condition that would interfere with study compliance

          -  Known hypersensitivity to 5-FU or capecitabine

          -  Anticipated inability to tolerate oral administration of SGX201

          -  Pregnant or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Horgan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soligenix</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.soligenix.com</url>
    <description>Sponsor</description>
  </link>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2010</study_first_submitted>
  <study_first_submitted_qc>February 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2010</study_first_posted>
  <last_update_submitted>December 12, 2012</last_update_submitted>
  <last_update_submitted_qc>December 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Enteritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Beclomethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

